Transfection of avian LMH-2A hepatoma cells with cationic lipids.
LMH-2A is an estrogen-responsive avian hepatoma cell line whose susceptibility to cationic-lipid-mediated transfection is poorly described. 3 beta[N-N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DCC) requires a one-step synthesis, and can be used to formulate transfection-grade liposomes when combined with dioleoylphosphatidyl-ethanolamine (DOPE) 1/1 (wt/wt). Luciferase activities in LMH-2A cells were 8.5-fold and 87.5-fold greater than those in HepG2 and FTO2B cells, respectively, following DCC-liposome-mediated transfection with a reporter consisting of the human cytomegalovirus immediate-early promoter (CMV), joined to Photinus pyralis luciferase (L) cDNA, designated pCMVL. Using pCMVL, N-(2-bromoethyl)-N,N-dimethyl-2,3-bis(9-octadecenyloxy)-propana minimun bromide) (BMOP)/DOPE 1/1 (wt/wt), at a 7.5:1 ratio with DNA, produced luciferase activities that were 2.9-fold higher than those of DCC-liposomes, at an optimal 10:1 lipid:DNA ratio. At optimal lipid:DNA ratios, commercially available liposomes, Transfectam, Lipofectamine, and Lipofectin, produced luciferase activities that were 1.39, 1.03, and 0.47-fold those of DCC-liposomes. The effect of 0, 10, 100, or 500 nM/L 17 beta-estradiol on the expression of pCMVL and a second luciferase reporter containing the -593/+48 promoter region of the estrogen-responsive avian apo VLDL-II gene, designated pApoL, was tested in cells cultured in the presence or absence of 10% chicken serum. The CMV promoter supported a high level of expression in LMH-2A cells that was unaffected by serum alone, but was weakly responsive to estrogen. Estrogen responses of both reporters reached a plateau at 10 nM/L. Estrogen increased the expression of pApoL 24-fold and 79-fold in the absence and presence of serum, respectively. The -593/+48 region of the apo VLDL-II promoter may not contain previously reported negative insulin response elements, but chicken serum contains factors that enhance estrogen responsiveness of this region.
Walzem
R L
RL
Department of Molecular Biosciences, School of Veterinary Medicine, University of California-Davis 95616, USA.
Hickman
M A
MA
German
J B
JB
Hansen
R J
RJ
D000704:Analysis of Variance; D000818:Animals; D001715:Bird Diseases / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D001717:Birds; D001798:Blood Proteins / Q000494:pharmacology; D002412:Cations; D001517:Coleoptera; D004247:DNA / Q000032:analysis / Q000235:genetics; D004967:Estrogens / Q000494:pharmacology; D015971:Gene Expression Regulation, Enzymologic; D017930:Genes, Reporter; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids / Q000235:genetics*; D008081:Liposomes; D008114:Liver Neoplasms, Experimental / Q000201:enzymology / Q000235:genetics* / Q000473:pathology*; D008156:Luciferases / Q000032:analysis / Q000235:genetics / Q000378:metabolism; D010957:Plasmids; D011401:Promoter Regions, Genetic / Q000235:genetics; D014162:Transfection; D014407:Tumor Cells, Cultured
D001798:Blood Proteins; D002412:Cations; D004967:Estrogens; D008055:Lipids; D008081:Liposomes; D004247:DNA; D008156:Luciferases